Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Zinc insulin |
Is a |
True |
Insulin |
Inferred relationship |
Some |
|
langtidsvirkende insulin |
Is a |
False |
Insulin |
Inferred relationship |
Some |
|
Beef insulin |
Is a |
True |
Insulin |
Inferred relationship |
Some |
|
semisyntetisk human insulin |
Is a |
False |
Insulin |
Inferred relationship |
Some |
|
Pork insulin |
Is a |
True |
Insulin |
Inferred relationship |
Some |
|
Intermediært virkende insulin |
Is a |
False |
Insulin |
Inferred relationship |
Some |
|
Rapid-acting insulin |
Is a |
False |
Insulin |
Inferred relationship |
Some |
|
Human insulin |
Is a |
True |
Insulin |
Inferred relationship |
Some |
|
Insulin, total measurement |
Has measured component |
False |
Insulin |
Inferred relationship |
Some |
|
Insulin, free measurement |
Has measured component |
False |
Insulin |
Inferred relationship |
Some |
|
Insulin challenge tests (procedure) |
Has measured component |
False |
Insulin |
Inferred relationship |
Some |
|
Insulin lipohypertrophy (disorder) |
Causative agent |
True |
Insulin |
Inferred relationship |
Some |
1 |
Insulin lipoatrophy |
Causative agent |
True |
Insulin |
Inferred relationship |
Some |
1 |
Insulin-induced anaphylaxis |
Causative agent |
True |
Insulin |
Inferred relationship |
Some |
1 |
Insulin coma |
Causative agent |
True |
Insulin |
Inferred relationship |
Some |
1 |
Accidental insulin poisoning |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
|
forgiftning med insulin, uvist med hvilken hensigt |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
1 |
forgiftning med tolbutamid, uvist med hvilken hensigt |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
|
Insulin adverse reaction |
Causative agent |
True |
Insulin |
Inferred relationship |
Some |
1 |
bivirkning af opløseligt neutral insulin |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
1 |
bivirkning af bifasisk insulin |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
|
bivirkning af bifasisk isophaninsulin |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
|
bivirkning af Humulin insulin |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
|
Initard insulin adverse reaction |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
|
Pur-In-Mix insulin adverse reaction |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
|
Mixtard insulin adverse reaction |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
|
Insulin overdose |
Causative agent |
True |
Insulin |
Inferred relationship |
Some |
1 |
Accidental insulin overdose |
Causative agent |
True |
Insulin |
Inferred relationship |
Some |
1 |
Intentional insulin overdose |
Causative agent |
True |
Insulin |
Inferred relationship |
Some |
1 |
overdosis af insulin, uvist med hvilken hensigt |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
1 |
Anti-insulin antibody |
Direct substance |
False |
Insulin |
Inferred relationship |
Some |
|
Insulin measurement |
Has measured component |
False |
Insulin |
Inferred relationship |
Some |
|
Insulin antibody measurement |
Has measured component |
False |
Insulin |
Inferred relationship |
Some |
|
Immunoreactive insulin measurement (procedure) |
Has measured component |
False |
Insulin |
Inferred relationship |
Some |
|
Insulin C-peptide measurement |
Has measured component |
False |
Insulin |
Inferred relationship |
Some |
|
Serum insulin measurement |
Has measured component |
False |
Insulin |
Inferred relationship |
Some |
|
Serum insulin - C-polypeptide measurement |
Has measured component |
False |
Insulin |
Inferred relationship |
Some |
|
Insulin, total measurement |
Component |
True |
Insulin |
Inferred relationship |
Some |
1 |
Insulin, free measurement |
Component |
True |
Insulin |
Inferred relationship |
Some |
1 |
Insulin challenge tests (procedure) |
Component |
True |
Insulin |
Inferred relationship |
Some |
1 |
Insulin measurement |
Component |
True |
Insulin |
Inferred relationship |
Some |
1 |
Insulin antibody measurement |
Component |
False |
Insulin |
Inferred relationship |
Some |
|
Immunoreactive insulin measurement (procedure) |
Component |
True |
Insulin |
Inferred relationship |
Some |
1 |
Insulin C-peptide measurement |
Component |
True |
Insulin |
Inferred relationship |
Some |
2 |
Serum insulin measurement |
Component |
False |
Insulin |
Inferred relationship |
Some |
2 |
Serum insulin - C-polypeptide measurement |
Component |
True |
Insulin |
Inferred relationship |
Some |
2 |
Beef insulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
Porcine insulin product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
intermediært virkende insulin-produkt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
langtidsvirkende insulin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
Poisoning by insulin |
Causative agent |
True |
Insulin |
Inferred relationship |
Some |
1 |
Intentional insulin poisoning |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
|
Allergy to insulin |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
|
allergi over for opløseligt neutral insulin |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
|
Allergy to zinc insulin |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
|
allergi over for insulin-zink-suspension (amorf) |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
|
allergi over for insulin-zink-suspension (krystallinsk) |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
|
Allergy to isophane insulin |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
|
korttidsvirkende insulin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
bovint insulin zink suspension 100 enheder/ml injektionsvæske, suspension, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
humant insulin zink suspension 100 enheder/ml injektionsvæske, suspension, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
insulin zink med forlænget virkning 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
bovint insulin protamin zink 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
opløseligt bovint insulin 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
opløseligt bovint insulin 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
bovint insulin isofan 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
opløseligt porcint insulin 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
opløseligt porcint insulin 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
porcint insulin isofan 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
porcint insulin isofan 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
bifasisk porcint insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
bifasisk porcint insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
bovint og porcint insulin zink suspension 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
bifasisk insulin |
Is a |
False |
Insulin |
Inferred relationship |
Some |
|
Insulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Insulin |
Inferred relationship |
Some |
1 |
Administration of insulin |
Direct substance |
False |
Insulin |
Inferred relationship |
Some |
1 |
fiskeinsulin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
Insulin isophane porcine 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic porcine 30/70 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
opløseligt bovint insulin 100 enheder/ml injektionsvæske, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
Insulin soluble porcine 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
Insulin isophane porcine 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
bovint insulin isofan 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
Insulin soluble porcine 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
bovin isofaninsulin 100 enheder/ml injektionsvæske, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic porcine 30/70 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
opløseligt bovint insulin 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
Plasma insulin C-peptide level (procedure) |
Component |
True |
Insulin |
Inferred relationship |
Some |
2 |
Plasma insulin measurement (procedure) |
Component |
False |
Insulin |
Inferred relationship |
Some |
2 |
Insulin human antibody measurement |
Component |
False |
Insulin |
Inferred relationship |
Some |
|
Insulin bovine antibody measurement |
Component |
False |
Insulin |
Inferred relationship |
Some |
|
Insulin pork antibody measurement |
Component |
False |
Insulin |
Inferred relationship |
Some |
|
Pork insulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
Adverse reaction to insulins and antidiabetic agents NOS |
Causative agent |
False |
Insulin |
Inferred relationship |
Some |
|
korttidsvirkende insulin |
Is a |
False |
Insulin |
Inferred relationship |
Some |
|
Product containing isophane insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
insulin isofan NPH |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin |
Inferred relationship |
Some |
|
fiskeinsulin |
Is a |
False |
Insulin |
Inferred relationship |
Some |
|
Sliding scale insulin regime |
Direct substance |
True |
Insulin |
Inferred relationship |
Some |
2 |
Insulin regime |
Direct substance |
True |
Insulin |
Inferred relationship |
Some |
2 |
Subcutaneous injection of insulin (procedure) |
Direct substance |
False |
Insulin |
Inferred relationship |
Some |
1 |